AptarGroup (ATR) Reports Q1 2026 Earnings Results
AptarGroup (ATR) reported Q1 2026 earnings with an 11% increase in sales, though core sales were flat. Adjusted EBITDA rose 3% to $189 million, but adjusted EPS declined due to higher expenses. The Pharma segment faced challenges, while Beauty and Closures segments showed mixed performance.
Tickers: $ATR
Topics: Beauty segment Closures segment earnings EBITDA Pharma segment sales growth